{"article": {"id": "Immigration1.0-40202", "title": "TOXIC PATIENT"}, "title_result": "\n                                                                                    AHF Calls on Gilead for Major Price Cut on PrEP Drug Descovy Following FDA Approval;Next-generation HIV prevention pill, which has fewer toxic side effects than Gilead's inferior prior drug, Truvada, was approved by the FDA Thursday for use as pre-exposure prophylaxis.;Both drugs cost about $1,800 a month per patient. AHF cites the billions of dollars Gilead has already made on its roster of HIV/AIDS drugs as well as its willful promotion and sales of Truvada, the more toxic earlier form of the drug, (tenofovir disoproxil fumarate) that causes permanent kidney and bone damage.\n                                                                                ", "title_match": false, "downloaded": true, "found": true}